Fig. 1 | Hypertension Research

Fig. 1

From: Therapeutic target and clinical impact of day-to-day blood pressure variability in hypertensive patients with covid-19

Fig. 1

Hazzard Ratio Base on: (A) Hypertension controlled status; (B) COVID-19 severity; (C) BPV status; (D) Combination of patients category; (E) Antihypertension drug. UC HTN Uncontrolled hypertension, C HTN Controlled hypertension, BPV Blood pressure. variability, BB Beta blockers, ACEi Angiotensin converting enzyme inhibitors, ARBs Angiotensin receptor blockers, CCBs calcium channel blockers

Back to article page